APP and autoimmune encephalitis: ,90,91,92In vivo LXR knock-out exacerbates autoimmunity in WT mice and amyloid-β pathology in APP/PS1 mice, while agonism ameliorates pathology in experimental autoimmune encephalitis and intracerebral haemorrhage.89